Patient with Rare Cancer Shares Long Journey Towards Diagnosis

Video

In part 2, Beth Wallace describes the events leading up to her diagnosis with leiomyosarcoma.

In part 2, Beth Wallace describes the events leading up to her diagnosis with leiomyosarcoma. Watch part 1 here.

Related Videos
Female Pharmacist Holding Tablet PC - Image credit: Tyler Olson | stock.adobe.com
pain management palliative care/Image Credits: © Aleksej - stock.adobe.com
African American male pharmacist using digital tablet during inventory in pharmacy - Image credit: sofiko14 | stock.adobe.com
palliative and hospice care/ Image Credits: © David Pereiras - stock.adobe.com
Young woman using smart phone,Social media concept. - Image credit: Urupong | stock.adobe.com
cancer pain management | Image Credits: © Burlingham - stock.adobe.com
multiple myeloma clinical trial daratumumab/ Image Credits: © Dragana Gordic - stock.adobe.com
multiple myeloma clinical trial/Image Credits: © Studio Romantic - stock.adobe.com
3d rendered illustration of lung cancer 3D illustration - Image credit: appledesign | stock.adobe.com
Related Content
FDA Grants Osimertinib Priority Review for Patients With Unresectable, Stage III EGFR-Mutated Lung Cancer

FDA Grants Osimertinib Priority Review for Patients With Unresectable, Stage III EGFR-Mutated Lung Cancer

Alexandra Gerlach, Associate Editor
June 10th 2024
Article
Pharmacy Focus: The Role of Pharmacists in Promoting Mental Health Care

Pharmacy Focus: The Role of Pharmacists in Promoting Mental Health Care

June 7th 2024
Podcast
FDA Approves Tirbanibulin for Actinic Keratosis on Expanded Area of Face or Scalp

FDA Approves Tirbanibulin for Actinic Keratosis on Expanded Area of Face or Scalp

Aislinn Antrim, Assistant Managing Editor
June 10th 2024
Article
Pharmacy Focus: Oncology Edition- Pharmacists Pivotal Role in Driving Clinical Trial Research

Pharmacy Focus: Oncology Edition- Pharmacists Pivotal Role in Driving Clinical Trial Research

May 28th 2024
Podcast
FDA Approves Imetelstat for Lower-Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia

FDA Approves Imetelstat for Lower-Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia

Aislinn Antrim, Assistant Managing Editor
June 7th 2024
Article
Intravenous injection -- Image credit: Nekrasov | stock.adobe.com

Inebilizumab-Cdon Reduces Risk of IgG4-Related Disease Flares By 87% In Adult Patients

Gillian McGovern, Assistant Editor
June 7th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.